Literature DB >> 16831695

Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing - Japanese experience.

Hisao Yugi1, Masaaki Mizui, Junko Tanaka, Hiroshi Yoshizawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831695     DOI: 10.1016/s1386-6532(06)80010-7

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


× No keyword cloud information.
  5 in total

1.  Criteria for hepatitis B virus screening and validation of blood components in Italy: the position of the SIMTI HBV working group.

Authors:  Claudio Velati; Laura Fomiatti; Lorella Baruffi; Vanessa Piccinini; Daniele Prati; Anna Reina; Andrea Lobbiani; Alessandro Zanetti; Luisa Romanò
Journal:  Blood Transfus       Date:  2011-07-21       Impact factor: 3.443

2.  Occult hepatitis B virus infection among Egyptian blood donors.

Authors:  Zeinab N Said; Manal H El Sayed; Iman I Salama; Enas K Aboel-Magd; Magda H Mahmoud; Maged El Setouhy; Faten Mouftah; Manal B Azzab; Heidi Goubran; Amal Bassili; Gamal E Esmat
Journal:  World J Hepatol       Date:  2013-02-27

3.  Reducing the risk of hepatitis B virus transfusion-transmitted infection.

Authors:  Christoph Niederhauser
Journal:  J Blood Med       Date:  2011-07-18

4.  Comparison of Procleix Ultrio Elite and Procleix Ultrio NAT Assays for Screening of Transfusion Transmitted Infections among Blood Donors in India.

Authors:  Rahul Chaurasia; Diptiranjan Rout; Shamsuz Zaman; Kabita Chatterjee; Hem Chandra Pandey; Abhishek Kumar Maurya
Journal:  Int J Microbiol       Date:  2016-01-19

5.  High prevalence of hepatitis B infections in Burkina Faso (1996-2017): a systematic review with meta-analysis of epidemiological studies.

Authors:  Moussa Lingani; Tomoyuki Akita; Serge Ouoba; Armel Moumini Sanou; Aya Sugiyama; Zekiba Tarnagda; Masayuki Ohisa; Halidou Tinto; Shunji Mishiro; Junko Tanaka
Journal:  BMC Public Health       Date:  2018-04-25       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.